ArticleArquivos de gastroenterologia2026
SEROLOGICAL CLEARANCE OF HBSAG IN CHRONIC HEPATITIS B: EXPERIENCE IN A UNIVERSITY HOSPITAL.
Article in Arquivos de gastroenterologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic hepatitis B virus (HBV) infection represents a major public health problem due to its high morbidity and mortality associated with liver cirrhosis and hepatocellular carcinoma. Functional cure, characterized by serological clearance of the HBV surface antigen (HBsAg), is the main therapeutic goal, since sterilizing viral eradication is not yet feasible. HBsAg clearance rates vary widely in the literature, and understanding the factors associated with this event is crucial for optimizing patient management.
objectiveTo investigate the HBsAg clearance rate and identify the demographic, clinical, and virological factors associated with this event in a cohort of patients with chronic hepatitis B virus infection followed up at a reference center in Northeast Brazil.
methodsA retrospective cohort study was conducted through a review of the medical records of patients with chronic hepatitis B virus infection treated at a Hepatology Service in Northeast Brazil between January 2015 and October 2025. Clinical, demographic and laboratory variables were analyzed. Statistical analysis used tests such as Mann-Whitney for quantitative variables and Fisher's exact test for categorical variables, in addition to the construction of Kaplan-Meier curves with the Log-Rank test to evaluate HBsAg clearance. The significance level was set at P<0.05.
resultsOf the 600 medical records screened, 299 patients were included in the analysis, 63.2% of whom were women, with a median age of 45 years. During a mean follow-up period of 5.14 years, totaling 1,538 person-years, 12 patients (4%) achieved serological clearance of HBsAg, resulting in an annual rate of 0.78%. Statistical analysis revealed significant associations between HBsAg clearance and advanced age (P=0.008) and lower HBV-DNA levels (P=0.0156).
conclusionThe annual rate of HBsAg serological clearance in this cohort was 0.78%. Advanced age and low viral load levels were significantly associated with functional cure. These findings enrich the knowledge about the natural history of chronic hepatitis B in the region and reaffirm the importance of viral suppression in disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.